These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 33879885)

  • 1. Sharing COVID data? Check these recommendations and guidelines.
    Hanahoe H; Austin CC; Shanahan H
    Nature; 2021 Apr; 592(7855):507. PubMed ID: 33879885
    [No Abstract]   [Full Text] [Related]  

  • 2. SARS-CoV-2 virtual biochemistry labs on bioinformatics and drug design.
    Brandt GS; Novak WRP
    Biochem Mol Biol Educ; 2021 Jan; 49(1):26-28. PubMed ID: 33301634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A doubt of multiple introduction of SARS-CoV-2 in Italy: A preliminary overview.
    Giovanetti M; Angeletti S; Benvenuto D; Ciccozzi M
    J Med Virol; 2020 Sep; 92(9):1634-1636. PubMed ID: 32190908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CoV-Seq, a New Tool for SARS-CoV-2 Genome Analysis and Visualization: Development and Usability Study.
    Liu B; Liu K; Zhang H; Zhang L; Bian Y; Huang L
    J Med Internet Res; 2020 Oct; 22(10):e22299. PubMed ID: 32931441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2).
    Sarkar B; Ullah MA; Johora FT; Taniya MA; Araf Y
    Immunobiology; 2020 May; 225(3):151955. PubMed ID: 32517882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics helping to mitigate the impact of COVID-19 - Editorial.
    Cannataro M; Harrison A
    Brief Bioinform; 2021 Mar; 22(2):613-615. PubMed ID: 33693516
    [No Abstract]   [Full Text] [Related]  

  • 7. Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19.
    Li R; Wu K; Li Y; Liang X; Tse WKF; Yang L; Lai KP
    Aging (Albany NY); 2020 Aug; 12(15):15784-15796. PubMed ID: 32805728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The «moonlighting protein» able to explain the T
    Roncati L; Lusenti B
    Med Hypotheses; 2020 Oct; 143():110087. PubMed ID: 32679426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications.
    Farsalinos K; Eliopoulos E; Leonidas DD; Papadopoulos GE; Tzartos S; Poulas K
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.
    Shojaee A; Vahedian-Azimi A; Faizi F; Rahimi-Bashar F; Shahriary A; Galeh HEG; Nehrir B; Guest PC; Sahebkar A
    Adv Exp Med Biol; 2021; 1321():53-68. PubMed ID: 33656713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
    Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
    ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19.
    Sadat SM; Aghadadeghi MR; Yousefi M; Khodaei A; Sadat Larijani M; Bahramali G
    Mol Biotechnol; 2021 May; 63(5):389-409. PubMed ID: 33625681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor.
    Souza PFN; Lopes FES; Amaral JL; Freitas CDT; Oliveira JTA
    Int J Biol Macromol; 2020 Dec; 164():66-76. PubMed ID: 32693122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A main event and multiple introductions of SARS-CoV-2 initiated the COVID-19 epidemic in Greece.
    Spanakis N; Kassela K; Dovrolis N; Bampali M; Gatzidou E; Kafasi A; Froukala E; Stavropoulou A; Lilakos K; Veletza S; Tsiodras S; Tsakris A; Karakasiliotis I
    J Med Virol; 2021 May; 93(5):2899-2907. PubMed ID: 33410223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten challenging questions about SARS-CoV-2 and COVID-19.
    Teymoori-Rad M; Samadizadeh S; Tabarraei A; Moradi A; Shahbaz MB; Tahamtan A
    Expert Rev Respir Med; 2020 Sep; 14(9):881-888. PubMed ID: 32536226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data sharing in the era of COVID-19.
    Cosgriff CV; Ebner DK; Celi LA
    Lancet Digit Health; 2020 May; 2(5):e224. PubMed ID: 32373785
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID19-world: a shiny application to perform comprehensive country-specific data visualization for SARS-CoV-2 epidemic.
    Tebé C; Valls J; Satorra P; Tobías A
    BMC Med Res Methodol; 2020 Sep; 20(1):235. PubMed ID: 32958001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Africa's contribution to the science of the COVID-19/SARS-CoV-2 pandemic.
    Kana MA; LaPorte R; Jaye A
    BMJ Glob Health; 2021 Mar; 6(3):. PubMed ID: 33648978
    [No Abstract]   [Full Text] [Related]  

  • 19. Detectable Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Human Breast Milk of a Mildly Symptomatic Patient With Coronavirus Disease 2019 (COVID-19).
    Tam PCK; Ly KM; Kernich ML; Spurrier N; Lawrence D; Gordon DL; Tucker EC
    Clin Infect Dis; 2021 Jan; 72(1):128-130. PubMed ID: 32472683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines for Pregnancy Management During the COVID-19 Pandemic: A Public Health Conundrum.
    Benski C; Di Filippo D; Taraschi G; Reich MR
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33182412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.